BusinessAdamas Presents Additional Open-Label, Long-Term Safety and Efficacy Data on ADS-5102 at the First Pan American Parkinson’s Disease and Movement Disorders CongressBy Nasdaq OMXFeb 28, 2017, 1:31 PM UTC
BusinessAdamas Presents Additional Open-Label, Long-Term Safety and Efficacy Data on ADS-5102 at the First Pan American Parkinson’s Disease and Movement Disorders CongressBy Nasdaq OMXFeb 28, 2017, 1:31 PM UTC